OTC Markets OTCPK - Delayed Quote USD

Biophytis S.A. (BPTSY)

2.0800
0.0000
(0.00%)
At close: May 13 at 4:00:00 PM EDT
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
0
0
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expense
12,199
14,333
23,271
26,815
13,942
Operating Income
-12,199
-14,333
-23,271
-26,815
-13,942
Net Non Operating Interest Income Expense
-2,240
-1,407
-2,465
-2,526
-1,500
Other Income Expense
-641
-1,287
1,521
-1,822
-10,075
Pretax Income
-15,079
-17,026
-24,216
-31,164
-25,517
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-15,074
-17,026
-24,216
-31,163
-25,517
Diluted NI Available to Com Stockholders
-15,074
-17,026
-24,216
-31,163
-25,517
Basic EPS
-41.80
-120.00
-560.00
-1.04k
-1.72k
Diluted EPS
-41.80
-120.00
-560.00
-1.04k
-1.72k
Basic Average Shares
269.8230
135.7680
43.7100
29.5710
14.9940
Diluted Average Shares
523.2000
135.7680
43.7100
29.5710
14.9940
Total Operating Income as Reported
-12,199
-14,333
-23,272
-26,815
-13,942
Total Expenses
12,199
14,333
23,271
26,815
13,942
Net Income from Continuing & Discontinued Operation
-15,074
-17,026
-24,216
-31,163
-25,517
Normalized Income
-13,847
-15,739
-25,737
-29,341
-15,442
Interest Expense
1,155
1,094
1,597
544
817
Net Interest Income
-2,240
-1,407
-2,465
-2,526
-1,500
EBIT
-13,924
-15,932
-22,619
-30,620
-24,700
EBITDA
-13,229
-15,129
-22,135
-30,309
-24,420
Reconciled Cost of Revenue
0
0
0
0
0
Reconciled Depreciation
695
803
484
311
280
Net Income from Continuing Operation Net Minority Interest
-15,074
-17,026
-24,216
-31,163
-25,517
Total Unusual Items Excluding Goodwill
-1,227
-1,287
1,521
-1,822
-10,075
Total Unusual Items
-1,227
-1,287
1,521
-1,822
-10,075
Normalized EBITDA
-12,002
-13,842
-23,656
-28,487
-14,345
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2020 - 2/10/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BPTH Bio-Path Holdings, Inc.
0.1600
-5.88%
 
SCPH scPharmaceuticals Inc.
2.3200
-6.45%
 
IMUX Immunic, Inc.
0.9898
+0.31%
 
RYTM Rhythm Pharmaceuticals, Inc.
56.79
-3.69%
 
ONCY Oncolytics Biotech Inc.
0.5340
-0.84%
 
DNLI Denali Therapeutics Inc.
14.26
-3.65%
 
ARVN Arvinas, Inc.
6.29
-3.53%
 
MCRB Seres Therapeutics, Inc.
7.37
-6.47%
 
ATYR aTyr Pharma, Inc.
3.3100
+2.16%
 
RPRX Royalty Pharma plc
32.82
-1.59%